Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 18275990)

1.

Cyclooxygenase-2 in cervical neoplasia: a review.

Young JL, Jazaeri AA, Darus CJ, Modesitt SC.

Gynecol Oncol. 2008 Apr;109(1):140-5. doi: 10.1016/j.ygyno.2008.01.008. Epub 2008 Feb 13. Review.

PMID:
18275990
2.
3.

Immunohistochemical evaluation of COX-2 expression in HPV-positive cervical squamous intraepithelial lesions.

Balan R, Amălinei C, Giuşcă SE, Ditescu D, Gheorghiţă V, Crauciuc E, Căruntu ID.

Rom J Morphol Embryol. 2011;52(1):39-43.

4.

Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer.

Mitchell A, Newton JM, Brite K, Einspahr J, Ellis M, Davis J, Nuno T, Alberts DS, Garcia F.

J Low Genit Tract Dis. 2007 Apr;11(2):80-5.

PMID:
17415111
5.

Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix.

Sarian LO, Derchain SF, Yoshida A, Vassallo J, Pignataro F, De Angelo Andrade LA.

Gynecol Oncol. 2006 Sep;102(3):537-41. Epub 2006 Mar 13.

PMID:
16537091
6.

Cyclooxygenase-2 expression in cervical intraepithelial neoplasia.

Kim K, Jeon YT, Park IA, Kim JW, Park NH, Kang SB, Lee HP, Song YS.

Ann N Y Acad Sci. 2009 Aug;1171:111-5. doi: 10.1111/j.1749-6632.2009.04724.x.

PMID:
19723044
7.

Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Favalli C, Syrjänen K; HPV-Pathogen Istituto Superiore di Sanità Study Group.

J Clin Pathol. 2006 Oct;59(10):1044-51. Epub 2006 Mar 14.

8.

Prognostic significance of cyclooxygenase-2 in cervical cancer: a meta-analysis.

Huang M, Chen Q, Xiao J, Liu C, Zhao X.

Int J Cancer. 2013 Jan 15;132(2):363-73. doi: 10.1002/ijc.27686. Epub 2012 Aug 3.

PMID:
22729746
9.

Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.

Chen HH, Su WC, Chou CY, Guo HR, Ho SY, Que J, Lee WY.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1093-100. Epub 2005 Aug 15.

PMID:
16099602
10.

Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers.

Fujimoto J, Toyoki H, Sato E, Sakaguchi H, Jahan I, Alam SM, Tamaya T.

J Biomed Sci. 2006 Nov;13(6):825-32. Epub 2006 Oct 1.

PMID:
17013750
11.

Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays.

Kim JY, Lim SJ, Park K, Lee CM, Kim J.

Gynecol Oncol. 2005 May;97(2):337-41.

PMID:
15863127
12.

Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer.

Manchana T, Triratanachat S, Sirisabya N, Vasuratna A, Termrungruanglert W, Tresukosol D.

Gynecol Oncol. 2006 Mar;100(3):556-60. Epub 2005 Oct 21.

PMID:
16246405
13.

Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):822-9.

PMID:
15465199
14.

The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma.

Dai Y, Zhang X, Peng Y, Wang Z.

Gynecol Oncol. 2005 Apr;97(1):96-103.

PMID:
15790444
15.

Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1.

Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN.

Cancer Res. 2002 Jan 15;62(2):424-32. Erratum in: Cancer Res 2002 Mar 1;62(5):1579. Soeters Roggert P [corrected to Soeters Robbert P].

16.

Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.

Ferrandina G, Ranelletti FO, Legge F, Lauriola L, Salutari V, Gessi M, Testa AC, Werner U, Navarra P, Tringali G, Battaglia A, Scambia G.

Clin Cancer Res. 2003 Oct 1;9(12):4324-31.

17.

Cyclooxygenase-2 is overexpressed in human cervical cancer.

Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ.

Clin Cancer Res. 2001 Feb;7(2):429-34.

18.

Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.

Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Ruangvejvorachai P, Thorner PS, Siriaunkgul S.

Gynecol Oncol. 2009 Jan;112(1):241-7. doi: 10.1016/j.ygyno.2008.09.017. Epub 2008 Oct 31.

PMID:
18977022
19.

Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.

Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Anticancer Res. 2006 Mar-Apr;26(2B):1543-56.

20.

Medical treatment of cervical intraepithelial neoplasia II, III: an update review.

Kietpeerakool C, Srisomboon J.

Int J Clin Oncol. 2009 Feb;14(1):37-42. doi: 10.1007/s10147-008-0795-x. Epub 2009 Feb 20. Review.

PMID:
19225922
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk